KLHDC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.61348712168774E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.44255743303756E-12 |
Normal-vs-Stage2 |
4.06860000000675E-05 |
Normal-vs-Stage3 |
1.20069953979396E-10 |
Normal-vs-Stage4 |
5.85880000070205E-09 |
Stage1-vs-Stage2 |
9.119800E-01 |
Stage1-vs-Stage3 |
3.757800E-01 |
Stage1-vs-Stage4 |
3.425200E-01 |
Stage2-vs-Stage3 |
7.212800E-01 |
Stage2-vs-Stage4 |
5.981200E-01 |
Stage3-vs-Stage4 |
7.860400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.42494913038627E-12 |
Normal-vs-AfricanAmerican |
2.40899999948141E-09 |
Normal-vs-Asian |
2.733800E-01 |
Caucasian-vs-AfricanAmerican |
3.533000E-01 |
Caucasian-vs-Asian |
1.228190E-01 |
AfricanAmerican-vs-Asian |
6.363900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.21056506433115E-12 |
Normal-vs-Female |
9.59459955929276E-10 |
Male-vs-Female |
1.415590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.750500E-04 |
Normal-vs-Age(41-60Yrs) |
1.53820001180804E-09 |
Normal-vs-Age(61-80Yrs) |
5.17508258468524E-12 |
Normal-vs-Age(81-100Yrs) |
2.28480000474818E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.871600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.958800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.269900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.014600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.251800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.865020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.419900E-04 |
Normal-vs-Grade 2 |
1.51090000510834E-08 |
Normal-vs-Grade 3 |
1.62536650805123E-12 |
Normal-vs-Grade 4 |
7.48950013118588E-10 |
Grade 1-vs-Grade 2 |
6.233400E-01 |
Grade 1-vs-Grade 3 |
5.710400E-01 |
Grade 1-vs-Grade 4 |
7.924000E-01 |
Grade 2-vs-Grade 3 |
3.097800E-03 |
Grade 2-vs-Grade 4 |
1.263430E-01 |
Grade 3-vs-Grade 4 |
5.655000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.68085553756237E-12 |
Normal-vs-ccB subtype |
1.99909999998304E-07 |
ccA subtype-vs-ccB subtype |
6.438000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.41949834903721E-11 |
Normal-vs-N1 |
3.779200E-03 |
N0-vs-N1 |
6.794600E-01 |
|
|